OCE at ASCO Annual Meeting 2022
FDA Oncology Center of Excellence experts will join colleagues in clinical oncology to participate in panel discussions or present research findings during the American Society of Clinical Oncology (ASCO) Annual Meeting, held in Chicago and online June 3-7, 2022. View the presentation links for more information.
Friday, June 3
Education Session: Adjuvant Therapy and Value-Based Decisions for Kidney and Urothelial Cancers: Does Early to Treat Equal Healthy, Wealthy, and Wise?
Chair: Chana Weinstock, MD
Location: E451; Time: 1 pm CDT
Oral Abstract #9000: Outcomes of anti-PD-(L)1 therapy with or without chemotherapy (chemo) for first-line (1L) treatment of advanced non-small cell lung cancer (NSCLC) with PD-L1 score ≥50%: FDA pooled analysis
Speaker: Oladimeji Akinboro, MD, MPH
Location: Hall D1; Time: 1 pm CDT
Oral Abstract #9001: Outcomes of first-line immune checkpoint inhibitors with or without chemotherapy according to KRAS mutational status and PD-L1 expression in patients with advanced NSCLC: FDA pooled analysis
Speaker: Erica C. Nakajima, MD
Location: Hall D1; Time: 1:12 pm CDT
Education Session: New Drugs in Oncology: Incorporation into Practice
Chair: Steven Lemery, MD, MHS
Location: S100a; Time: 1 pm CDT
Education Session: What Else Is Out There: Careers Beyond Academia?
Speaker: Tatiana Prowell, MD
Location: E350; Time: 3:09 pm CDT
Saturday, June 4
Poster Abstract #4089: Antibiotic therapy and association with oncological outcomes from targeted and immune-based therapy in hepatocellular carcinoma
Presenter: Lorraine Pelosof, MD
Location: Hall A; Time: 8 am CDT
Poster Abstract #1529: FDA Analysis of Expanded Access Use in Pediatric Patients from 2015 to 2020
Speaker: Elizabeth Duke, MD
Location: Hall A; Time: 1:15 pm CDT
Education Session: Regulatory perspectives on expanding inclusion to clinical trials for patients with primary and metastatic Central Nervous System Cancer
Speaker: Gautam Mehta, MD
Location: S404; Time: 1:45 pm CDT
Education Session: ASCO Town Hall: The Future of the Conduct of Clinical Trials After COVID-19
Panel Speaker: Sundeep Agrawal, MD
Location: S102; Time: 3 pm CDT
Ticketed Session: Point/Counterpoint: Real-World Data—Do We Even Need Clinical Trials Anymore?
Speaker: Paul Kluetz, MD
Location: E253d; Time: 3:15 pm CDT
Cased-Based Panel: Practical Use of Geriatric Assessment Tools for Older Adults with Cancer: Can Technology Take Us Further?
Chair: Timil Patel, MD
Location: E350; Time: 4:45 pm CDT
Sunday, June 5
Panel Talk: Finding Your Niche in Oncology: Careers in Government
Speaker: Preeti Narayan, MD
Location: S501, Trainee & Early Career Oncologist Member Lounge
Time: 8 am CDT
Education Session: Paving the Way to Access: Understanding the Hurdles of Approvals Based on Neoadjuvant Trials
Speaker: Erin Larkins, MD
Location: Arie Crown Theater Time: 8:36 am CDT
Education Session: The Spectrum of Clinical Evidence: Real-World Data to Clinical Trials
Speaker: Donna Rivera, PharmD
Location: S404; Time: 9:57 am CDT
Patient Advocacy Session: A Dialogue with Patient Representatives & Advocates
Speakers: Richard Pazdur, MD; Paul Kluetz, MD; Preeti Narayan, MD; Erica Nakajima, MD; Bernardo Haddock Lobo Goulart, MD
Location: McCormick Place Room N228
Time: 10:30 am CDT
Monday, June 6
Education Session: Regulatory Rendezvous: A Conversation with Dr. Richard Pazdur, Director of the FDA Oncology Center of Excellence
Panelist: Richard Pazdur, MD
Location: E451; Time: 8 am CDT
Poster Abstract #9029: Association of Progression-Free Survival and Overall Response Rate with Overall Survival in First-Line Randomized Trials of Immune Checkpoint Inhibitor-Based Regimens for Metastatic Non-Small Cell Lung Cancer (NSCLC): an FDA Pooled Analysis
Presenter: Bernardo Haddock Lobo Goulart, MD
Location: Hall A, Poster 5; Time: 8 am CDT
Professional Development Panel: Non-Traditional Career Paths
Panelist: 'Lola Fashoyin-Aje, MD
Location: S502, Women's Networking Center; Time: 9:15 am CDT
Oral abstract Session: Care Delivery and Regulatory Policy
Co-Chair: Nicole Gormley, MD
Location: E450; Time: 3 pm CDT
Education Session: Impact of COVID-19 on U.S. Food and Drug Administration Regulation of Clinical Trials and Drug Approvals
Speaker: Jennifer Gao, MD
Location: S504; Time: 5:09 pm CDT
Publications Only
Project Facilitate: Innovation and advancement in FDA’s oncology expanded access program
First Author: Mitchell Chan, PharmD
Abstract: e18556
Updated FDA pooled analysis of pain medication use in trial participants with HR+, HER2-negative metastatic breast cancer treated with endocrine therapy and a CDK 4/6 inhibitor
Authors: Jennifer J. Gao, Andrew Girvin, Christine Hodgdon, Christy Osgood, Vishal Bhatnagar, Paul Kluetz, Richard Pazdur, Laleh Amiri-Kordestani, Julia A. Beaver
Abstract: e24101